Merck submits application for new Gardasil use

BOSTON, Apr 17 (Reuters) Merck&Co. Inc. said on Tuesday that it has submitted an application with U.S. regulators to market its cervical cancer vaccine Gardasil for vaginal and vulvar cancer also.

Gardasil vaccinates against a virus responsible for causing cervical cancer. The company said the U.S. Food and Drug Administration will determine whether it will accept Merck's new application for review within 60 days of its submission.

REUTERS DKS RN1909